Around 300 FDA staffers have been asked to return to work after Musk’s DOGE axed thousands of jobs from the Department of ...
Amgen invests $200M in India's tech center to leverage AI for drug development. The U.S. FDA seeks to rehire 300 staff ...
The FDA is trying to rehire 300 recently fired scientists, including some who reviewed Elon Musk's Neuralink. The move ...
The FDA plans to rehire around 300 people in total, according to four sources with secondhand knowledge of the situation, ...
At least 11 employees working at the FDA's Center for Devices and Radiological Health - which oversees medical device reviews ...
The U.S. Food and Drug Administration (FDA) is reaching out to recently fired scientists, asking them to return, including ...
Americans need “an efficient, effective FDA review process that helps advance the medical technologies American patients ...
The FDA is considering rehiring recently dismissed scientists who were involved in projects like Elon Musk's Neuralink. About ...
A U.S. watchdog group and other critics are responding with alarm to reporting that federal employees reviewing applications related to a brain implant developed by Elon Musk's company Neuralink are ...
Several U.S. Food and Drug Administration employees connected to reviewing Elon Musk’s brain interface company Neuralink have ...
The impact of these layoffs extends beyond the FDA. According to The New York Times, 11 federal agencies affected by DOGE’s workforce reductions are currently handling investigations, complaints, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results